Acetylcholine release in the rat prefrontal cortex in vivo: Modulation by α2-adrenoceptor agonists and antagonists

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 778-785

  Tellez, Stéphane ^a   Colpaert, Francis ^a   Marien, Marc ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Acetylcholine release; Alzheimer's disease; Intracerebral microdialysis; Rat medial prefrontal cortex; 2 Adrenoceptors

Indexed keywords

ACETYLCHOLINE; ALPHA 2 ADRENERGIC RECEPTOR; BRIMONIDINE; CLONIDINE; IDAZOXAN;

ACETYLCHOLINE RELEASE; ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; FACILITATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

EID: 0031030662     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020778.x     Document Type: Article

References (56)

1. 2 receptor selectivity and specificity of the antihypertensive agent moxonidine. Arzneimittelforsch. 38, 1435-1442.
2. 2 Adrenoceptor agonists induce mydriasis in the rat by an action within the central nervous system. Br. J. Pharmacol 78, 507-515.
3. Bondareff W., Mountjoy C. Q., and Roth M. (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology 32, 164-168.
4. 2-receptors in the hypothermia induced by clonidine in the rat. Neuropharmacology 19, 9-15.
5. 2-agonist for the characterization of α-adrenoceptor subtypes. Eur. J. Pharmacol. 72, 413-415.
6. 2-adrenoceptors. (Abstr.) Br. J. Pharmacol. 74, 842P.
7. Colpaert F. C. (1986a) Effects of putative α-adrenoceptor antagonists and of other compounds on the loss of the righting reflex and on exophthalmia induced by xylazine in the rat. Drug Dev. Res. 7, 125-140.
8. Colpaert F. C. (1986b) Maximal magnitude of effect and potency of putative α-adrenoceptor agonists in causing CNS depression, in relaxing muscle, and in lowering body temperature in rat. Drug Dev. Res. 7, 209-220.
9. Colpaert F. C. (1994) Noradrenergic mechanisms in Parkinson's disease: a theory, in Noradrenergic Mechanisms in Parkinson's Disease (Briley M. and Marien M., eds), pp. 225-254. CRC Press, Boca Raton, Florida.
10. 2 adrenoceptor agonists and antagonists. J. Pharmacol. Exp. Ther. 235, 521-527.
11. 2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type. Psychopharmacologv (Berlin) 123, 239-249.
12. Cuadra G. and Giacobini E. (1995) Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo. J. Pharmacol Exp. Ther. 273, 230-240.
13. 2-adrenoceptor antagonism. Br. J. Pharmacol. 78, 128P.
14. Damsma G., Lammerts van Bueren D., Westerink B. H. C., and Horn A. S. (1987) Determination of acetylcholine and choline in the femtomole range by means of HPLC, a postcolumn enzyme reactor, and electrochemical detection. Chromatographia 24, 827-831.
15. Day J., Damsma G., and Fibiger H. C. (1991) Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 38, 723-729.
16. Day J. C., Tham C.-S., and Fibiger H. C. (1994) Dopamme depletion attenuates amphetamine-induced increases of cortical acetylcholine release. Eur. J. Pharmacol. 263, 285-292.
17. Dennis T., L'Heureux R., Carter C., and Scatton B. (1987) Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J. Pharmacol Exp. Ther. 241, 642-649.
18. 2-adrenoceptor antagonist idazoxan (RX781094) in peripheral systems. Br. J. Pharmacol. 83, 713-722.
19. Fort P., Khateb A., Pegna A., Mühlethaler M., and Jones B. E. (1995) Noradrenergic modulation of cholinergic nucleus basalis neurons demonstrated by in vitro pharmacological and immuno-histochemical evidence in the guinea pig brain. J. Neurosci. 7, 1502-1511.
20. 14C]2-deoxyglucose and microdialysis studies. Neuropharmacology 34, 605-613.
21. Friedman P. (1991) GB-STAT: Computer Aided Statistics and Graphics, Ver. 3.0. Dynamic Microsystems, Silver Spring, Maryland.
22. 2-adrenoceptors in the rat. Br. J. Pharmacol. 83, 707-712.
23. 2-adrenoceptor. Pharmacol. Rev. 35, 143-180.
24. Grant J. A. and Scrutton M. C. (1980) Interaction of selective α-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br. J. Pharmacol. 71, 121-134.
25. Haeusler G. (1974) Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch. Pharmacol. 286, 97-111.
26. Hagan R. M. and Hughes I. E. (1986) Yohimbine affects the evoked overflow of neurotransmitters from rat brain slices by more than one mechanism. J. Pharm. Pharmacol 38, 195-200.
27. 2-adrenoceptor antagonist. Br. J. Pharmacol. 102, 887-895.
28. 2-adrenoceptors. Pharmacol. Biochem. Behav. 50, 219-224.
29. Inglis F. M. and Fibiger H. C. (1995) Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience 66, 81-86.
30. L'Heureux R., Dennis T., Curet O., and Scatton B. (1986) Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J. Neurochem. 46, 1794-1801.
31. 2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo. Eur. J. Pharmacol. 285, 255-260.
32. Lal H., Sharman G., Bennett D., and Horvat A. (1983) Yohimbine, a β-carboline with behavioural and neurochemical properties common to anxiogenic drugs. Soc. Neurosci. Abstr. 9, 437.
33. Marshall D. L. and Wurtman R. J. (1993) Effect of choline on basal and stimulated acetylcholine release: an in vivo microdialysis study using a low neostigmine concentration. Brain Res. 269, 269-274.
34. McEntee W. J. and Crook T. H. (1990) Age-associated memory impairment: a role for catecholamines. Neurology 40, 526-530.
35. Medgett I. C., McCulloch M. W., and Rand M. J. (1978) Partial agonist action of clonidine on prejunctional and postjunctional alpha-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 304, 215-221.
36. Messamore E., Warpman U., Ogane N., and Giacobini E. (1993) Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology 32, 745-750.
37. Michel M. C. and Ernsberger P. (1992) Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci. 13, 369-370.
38. alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline. J. Pharmacol. Exp. Ther. 270, 958-972.
39. Moroni F., Tanganelli S., Antonelli T., Carla V., Bianchi C., and Beani L. (1983) Modulation of cortical acetylcholine and γ-aminobutyric acid release in freely moving guinea pigs: effects of clonidine and other adrenergic drugs. J. Pharmacol. Exp. Ther. 227, 435-440.
40. Palmer A. M., Wilcock G. K., Esiri M. M., Francis P. T., and Bowen D. M. (1987) Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res. 401, 231-238.
41. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, Sydney.
42. Pineda J., Ugedo L., and Garcia-Sevilla J. A. (1993) Stimulatory effect of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurons: possible involvement of imidazoline-preferring receptors. Naunyn Schmiedebergs Arch. Pharmacol. 348, 134-140.
43. Riekkinen P. J., Sirvio J., Riekkinen P. Jr., Valjakka A., Jakala P., Koivisto E., and Lammintausta R. (1992) The role of the noradrenergic system in higher cerebral functions: experimental studies about the effects on noradrenergic modulation on electro-physiology and behavior, in Neurotransmitter Interactions and Cognitive Function (Levin E. D., Decker M. W., and Butcher L., eds), pp. 91-102. Birkhauser, Boston.
44. 2-adrenoceptors. J. Pharmacol. Exp. Ther. 227, 421-428.
45. Ruiz-Ortega J. A., Ugedo L., Pineda J., and Garcia-Sevilla J. A. (1995) The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurons is mediated by excitatory amino acids and modulated by serotomn. Naunyn Schmiedebergs Arch. Pharmacol. 352, 121-126.
46. 2 antagonist, facilitates memory retrieval in the rat. Behav. Neural Biol. 51, 401-411.
47. Scatton B., Zivkovic B., and Dedek J. (1980) Antidopaminergic properties of yohimbine. J. Pharmacol. Exp. Ther. 215, 494-499.
48. 2-adrenoceptor antagonist. Eur. J. Pharmacol. 151, 35-42.
49. 2-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo. Eur. J. Pharmacol. 277, 113-116.
50. 2-adrenoceptor agonists and antagonists. Soc. Neurosci. Abstr. 21, 2138.
51. 2-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves. Br. J. Pharmacol. 109, 655-660.
52. 2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther. 297, 190-204.
53. Winter J. C. and Rabin R. A. (1992) Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J. Pharmacol. Exp. Ther. 263, 682-689.
54. Wood P. L. and McQuade P. (1986) Substantia innominata-cortical cholinergic pathway: regulatory afferents, in Advances in Behavioral Biology, Vol. 30: Dynamics of Cholinergic Function (Hanin I., ed), pp. 991-999. Plenum Press, New York.
55. Zornetzer S. F. (1985) Catecholamine system involvement in aged-related memory dysfunction. Ann. NY Acad. Sci. 444, 242-254.
56. Zweig R., Ross C. A., Hedreen J. C., Steele C., Cardillo J. E., Whitehouse P. J., Folstein M. F., and Price D. L. (1988) The neuropathology of aminergic nuclei in Alzheimer's disease. Ann. Neurol. 24, 233-242.